These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29467523)

  • 21. Neurodevelopment at 24 months corrected age in extremely preterm infants treated with dexamethasone alternatives during the late postnatal period: a cohort study.
    Melan N; Pradat P; Godbert I; Pastor-Diez B; Basson E; Picaud JC
    Eur J Pediatr; 2024 Feb; 183(2):677-687. PubMed ID: 37955745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Amino Acids in Extremely Preterm Infants and Neurodisability at 2 Years.
    Bloomfield FH; Jiang Y; Harding JE; Crowther CA; Cormack BE;
    N Engl J Med; 2022 Nov; 387(18):1661-1672. PubMed ID: 36322845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurodevelopmental Outcomes of Extremely Preterm Infants Randomized to Stress Dose Hydrocortisone.
    Parikh NA; Kennedy KA; Lasky RE; Tyson JE
    PLoS One; 2015; 10(9):e0137051. PubMed ID: 26376074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].
    Jarreau PH; Fayon M; Baud O; Autret-Leca E; Danan M; de Verdelhan A; Castot A
    Arch Pediatr; 2010 Oct; 17(10):1480-7. PubMed ID: 20864322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
    Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
    JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between Baseline Cortisol Serum Concentrations and the Effect of Prophylactic Hydrocortisone in Extremely Preterm Infants.
    Renolleau C; Toumazi A; Bourmaud A; Benoist JF; Chevenne D; Mohamed D; Alberti C; Biran V; Baud O;
    J Pediatr; 2021 Jul; 234():65-70.e3. PubMed ID: 33359303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.
    Morris IP; Goel N; Chakraborty M
    Eur J Pediatr; 2019 Aug; 178(8):1171-1184. PubMed ID: 31144162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids.
    Chawla S; Natarajan G; Shankaran S; Pappas A; Stoll BJ; Carlo WA; Saha S; Das A; Laptook AR; Higgins RD;
    JAMA Pediatr; 2016 Dec; 170(12):1164-1172. PubMed ID: 27723868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dexamethasone, Prednisolone, and Methylprednisolone Use and 2-Year Neurodevelopmental Outcomes in Extremely Preterm Infants.
    Puia-Dumitrescu M; Wood TR; Comstock BA; Law JB; German K; Perez KM; Gogcu S; Mayock DE; Heagerty PJ; Juul SE;
    JAMA Netw Open; 2022 Mar; 5(3):e221947. PubMed ID: 35275165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.
    Marc I; Piedboeuf B; Lacaze-Masmonteil T; Fraser W; Mâsse B; Mohamed I; Qureshi M; Afifi J; Lemyre B; Caouette G; Bartholomew J; Nuyt AM; Julien P; Synnes A; Lucas M; Perreault T; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Massé E; Larsen B; de Cabo C; Ruth C; Khurshid F; Lavoie PM
    JAMA; 2020 Jul; 324(2):157-167. PubMed ID: 32662862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Marr BL; Mettelman BB; Bode MM; Gross SJ
    J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, double-blinded trial of low-dose dexamethasone: II. Functional residual capacity and pulmonary outcome in very low birth weight infants at risk for bronchopulmonary dysplasia.
    McEvoy C; Bowling S; Williamson K; McGaw P; Durand M
    Pediatr Pulmonol; 2004 Jul; 38(1):55-63. PubMed ID: 15170874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial.
    Bonsante F; Latorre G; Iacobelli S; Forziati V; Laforgia N; Esposito L; Mautone A
    Neonatology; 2007; 91(4):217-21. PubMed ID: 17568152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrocortisone use in ventilated extremely preterm infants decreased bronchopulmonary dysplasia with no effects on neurodevelopment after two years.
    Renault A; Patkaï J; Dassieu G; El Ayoubi M; Canouï-Poitrine F; Durrmeyer X
    Acta Paediatr; 2016 Sep; 105(9):1047-55. PubMed ID: 27239054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Association of Dexamethasone and Hydrocortisone with Cerebellar Growth in Premature Infants.
    Warmerdam LA; van Wezel-Meijler G; de Vries LS; Groenendaal F; Steggerda SJ
    Neonatology; 2023; 120(5):615-623. PubMed ID: 37379806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does duration of caffeine therapy in preterm infants born ≤1250 g at birth influence neurodevelopmental (ND) outcomes at 3 years of age?
    Lodha A; Rabi Y; Soraisham A; Dobry J; Lodha A; Amin H; Awad EA; Tang S; Sahai A; Bhandari V
    J Perinatol; 2018 Jul; 38(7):889-899. PubMed ID: 29740190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Systemic Hydrocortisone Initiated 7 to 14 Days After Birth in Ventilated Preterm Infants on Mortality and Neurodevelopment at 2 Years' Corrected Age: Follow-up of a Randomized Clinical Trial.
    Halbmeijer NM; Onland W; Cools F; Swarte R; van der Heide-Jalving M; Merkus MP; van Kaam AH;
    JAMA; 2021 Jul; 326(4):355-357. PubMed ID: 34313697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Systemic Hydrocortisone on Brain Abnormalities and Regional Brain Volumes in Ventilator-dependent Infants Born Preterm: Substudy of the SToP-BPD Study.
    Halbmeijer NM; Onland W; Dudink J; Cools F; Debeer A; van Kaam AH; Benders MJNL; van der Aa NE
    J Pediatr; 2024 Feb; 265():113807. PubMed ID: 37923196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.
    Cummings JJ; D'Eugenio DB; Gross SJ
    N Engl J Med; 1989 Jun; 320(23):1505-10. PubMed ID: 2657423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Glucocorticoide therapy in premature infants: French practices in 2006].
    Autret-Leca E; Bauer S; Alberti C; Jonville-Béra AP; Aujard Y; Bensouda-Grimaldi L; Baud O
    Arch Pediatr; 2009 Jul; 16(7):999-1004. PubMed ID: 19410441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.